Oocyte vitrification in women at risk of ovarian failure; an observational study with follow-up of children - Oocyte vitrification

Academisch Medisch Centrum0 个研究点目标入组 1,321 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•1. Women until their 40th birthday who are at risk of ovarian failure due to iatrogenic gonadotoxic treatment.
•2. Women until their 40th birthday who are at risk of premature ovarian failure and women between the ages of 30th and 40th birthday who are at risk of ovarian failure due to increasing age.
•3. Women until their 43rd birthday undergoing an IVF/ICSI cycle during which no spermatozoa can be obtained at the time of follicle aspiration.

•1. Women with borderline or invasive ovarian cancer.
•2. Women with contraindications for IVF treatment such as cardiovascular-pulmonary disease, severe diabetes, bleeding disorders, immunodeficiency, morbid obesity, and premature ovarian failure.
•3. Women with severe psychopathology, severe anxiety and inability to cope.
•4. Women who reach, at the time they request thawing of their oocyte, the maximum age at which embryo transfer is accepted by Dutch guidelines (currently from their 45th birthday).
•5. Not able or willing to provide informed consent.

发起方